How do regulations impact the development of biosimilars?
Biosimilars are biologic products highly similar to already approved “reference” biologics. Regulatory frameworks for biosimilars, like the Biologics Price Competition and Innovation Act (BPCIA) in the U.S., provide pathways for their approval. These regulations ensure that biosimilars meet rigorous standards for similarity, potency, and safety, thus offering more affordable treatment options.
